JP

Tasuku Honjo


USPTO Granted Patents = 5

% Expired Patents = 40.0

Forward Citations = 253

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Tasuku Honjo (5 out of 40 patents)

silverMedal Shiro Shibayama (2 out of 52 patents)

bronzeMedal Takao Yoshida (1 out of 13 patents)

4.  Takashi Shinohara (1 out of 15 patents)

5.  Kazuhiko Takeda (1 out of 8 patents)

6.  Nagahiro Minato (1 out of 14 patents)

7.  Masakazu Miyamoto (1 out of 9 patents)

8.  Hideaki Tada (1 out of 17 patents)

9.  Masayoshi Matsuo (1 out of 8 patents)

10.  Yoshiko Iwai (1 out of 8 patents)

11.  Akira Shimizu (1 out of 7 patents)

12.  Kei Tashiro (1 out of 11 patents)

13.  Yasumasa Ishida (1 out of 2 patents)


5 patents:

Company Overview
Tasuku Honjo is a Japanese immunologist who won the Nobel Prize in Physiology or Medicine in 2018 for his discovery of cancer therapy by inhibition of negative immune regulation. He is a professor in the Department of Immunology and Genomic Medicine at Kyoto University. His research focuses on understanding the mechanisms of immune regulation and applying that knowledge to develop new cancer immunotherapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#237 in

#6,652 in Japan

JP
JP
Forward Citations = 253

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tasuku Honjo. Retrieved from https://idiyas.com/company/tasuku-honjo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…